Arno Therapeutics, Inc Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)
Arno Therapeutics, Inc reported Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) of 108.00% for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExpectedVolatilityRate · last filed 2014-03-31
- Arno Therapeutics, Inc fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2013 was 108.00%, a 46.00% decline from fiscal 2012.
- Arno Therapeutics, Inc fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2012 was 200.00%, a 66.67% increase from fiscal 2011.
- Arno Therapeutics, Inc fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2011 was 120.00%.
| Period end | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|
| 2013-12-31 | 108.00% 10-K · filed 2014-03-31 | |
| 2013-09-30 | 178.00% 10-Q · filed 2013-11-14 | |
| 2012-12-31 | 200.00% 10-K · filed 2014-03-31 | |
| 2011-12-31 | 120.00% 10-K · filed 2013-04-01 |